Patent expiry and biosimilars: difference between revisions
Diff·revision 26 → 27·09:06, 22 Apr 2026
Difference between revision 26 and revision 27 of Patent expiry and biosimilars. This revision changed no lines of source — the edit was a null or whitespace change.
| Revision 26 — 01:30, 1 Apr 2026 Chromatokid (talk) add the note that this wiki does not give legal advice 4,553 bytes ±0 | Revision 27 — 09:06, 22 Apr 2026 AppendixAlva (talk) rm the claim that the position has changed; no source supports it 4,553 bytes ±0 | ||
|---|---|---|---|
| — | No change to the page source. | — |